Detalhe da pesquisa
1.
A Randomized, Double-Blind, Controlled Phase II Study of Foliglurax in Parkinson's Disease.
Mov Disord
; 37(5): 1088-1093, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218231
2.
A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9.
Eur J Clin Pharmacol
; 77(10): 1473-1484, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-33969434
3.
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Mov Disord
; 35(11): 1957-1965, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32882100
4.
An mGlu4-Positive Allosteric Modulator Alleviates Parkinsonism in Primates.
Mov Disord
; 33(10): 1619-1631, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30216534
5.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Mult Scler
; 22(2): 212-21, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25921050
6.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Mult Scler
; 21(4): 448-56, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25092769
7.
Responder definition of the Multiple Sclerosis Impact Scale physical impact subscale for patients with physical worsening.
Mult Scler
; 20(13): 1753-60, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740371
8.
Safety and Tolerability of Active Immunotherapy Targeting α-Synuclein with PD03A in Patients with Early Parkinson's Disease: A Randomized, Placebo-Controlled, Phase 1 Study.
J Parkinsons Dis
; 11(3): 1079-1089, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092654
9.
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants.
Eur Child Adolesc Psychiatry
; 19(4): 325-40, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19823900
10.
Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial.
Lancet Neurol
; 19(7): 591-600, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32562684
11.
Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Clin Ther
; 30(12): 2378-86, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19167596
12.
Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection.
Int Clin Psychopharmacol
; 23(6): 325-31, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18854720
13.
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
Nat Rev Drug Discov
; 17(11): 844, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30310231
14.
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
Nat Rev Drug Discov
; 17(11): 804-822, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30262889
15.
Remission in early psychosis: Rates, predictors, and clinical and functional outcome correlates.
Schizophr Res
; 89(1-3): 129-39, 2007 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17095194
16.
Efficacy and safety of risperidone long-acting injectable in stable psychotic patients previously treated with oral risperidone.
Int Clin Psychopharmacol
; 22(2): 85-92, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17293708
17.
Time course for antipsychotic treatment response in first-episode schizophrenia.
Am J Psychiatry
; 163(4): 743-5, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16585455
18.
Plasma antipsychotic concentration and receptor occupancy, with special focus on risperidone long-acting injectable.
Eur Neuropsychopharmacol
; 16(4): 233-40, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16326078
19.
Orally versus intramuscularly administered antipsychotic drugs in psychiatric emergencies.
J Psychiatr Pract
; 12(1): 30-40, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16432443
20.
[Switching from a short-acting to a long-acting methylphenidate preparation: a multicentre, open study in children with ADHD]. / Umstellung von einem unretardierten auf ein retardiertes Methyl phenidatpräparat: Eine multizentrische, offene Studie an Kindern mit ADHS.
Z Kinder Jugendpsychiatr Psychother
; 34(4): 257-65, 2006 Jul.
Artigo
em Alemão
| MEDLINE | ID: mdl-16927568